GOLDMAN SACHS GROUP INC - ACCELERATE DIAGNOSTICS INC ownership

ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 68 filers reported holding ACCELERATE DIAGNOSTICS INC in Q1 2023. The put-call ratio across all filers is 3.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACCELERATE DIAGNOSTICS INC
ValueSharesWeighting
Q4 2022$27,444
-37.6%
38,873
+33.8%
0.00%
Q3 2022$44,000
-2.2%
29,043
-36.6%
0.00%
Q2 2022$45,000
-67.6%
45,822
-52.7%
0.00%
Q1 2022$139,000
-31.2%
96,832
+150.1%
0.00%
Q4 2021$202,000
+169.3%
38,720
+201.7%
0.00%
Q3 2021$75,000
-80.8%
12,836
-73.5%
0.00%
Q2 2021$391,000
+44.8%
48,526
+49.2%
0.00%
Q1 2021$270,000
+14.4%
32,521
+4.4%
0.00%
Q4 2020$236,000
-18.6%
31,140
+14.2%
0.00%
Q3 2020$290,000
-79.3%
27,263
-70.5%
0.00%
Q2 2020$1,401,000
+95.9%
92,439
+7.6%
0.00%
Q1 2020$715,000
-18.4%
85,894
+65.7%
0.00%
Q4 2019$876,000
-0.8%
51,828
+9.0%
0.00%
Q3 2019$883,000
-61.1%
47,548
-52.1%
0.00%
-100.0%
Q2 2019$2,269,000
+14.9%
99,169
+5.6%
0.00%0.0%
Q1 2019$1,975,000
+45.2%
93,945
-20.5%
0.00%
Q4 2018$1,360,000
-39.2%
118,227
+21.4%
0.00%
-100.0%
Q3 2018$2,236,000
+19.2%
97,416
+15.8%
0.00%0.0%
Q2 2018$1,876,0000.0%84,105
+2.5%
0.00%
Q1 2018$1,876,000
-30.7%
82,085
-20.6%
0.00%
-100.0%
Q4 2017$2,708,000
+44.0%
103,352
+23.4%
0.00%
Q3 2017$1,880,000
-7.1%
83,746
+13.2%
0.00%
-100.0%
Q2 2017$2,024,000
+313.1%
74,013
+265.7%
0.00%
Q1 2017$490,000
+3.8%
20,238
+16.8%
0.00%
Q3 2016$472,000
-10.1%
17,328
-52.6%
0.00%
Q1 2016$525,000
+116.9%
36,556
+225.1%
0.00%
Q4 2015$242,000
-84.4%
11,244
-81.3%
0.00%
Q2 2015$1,553,000
+62.1%
60,179
+41.3%
0.00%
Q1 2015$958,000
-57.9%
42,592
-64.0%
0.00%
-100.0%
Q4 2014$2,273,000
-27.7%
118,441
-19.1%
0.00%0.0%
Q3 2014$3,143,000
+26.1%
146,336
+52.6%
0.00%0.0%
Q2 2014$2,493,000
-45.8%
95,880
-54.6%
0.00%
-50.0%
Q1 2014$4,601,000
+12.0%
210,963
-37.3%
0.00%
+100.0%
Q4 2013$4,107,000
+2942.2%
336,609
+3235.4%
0.00%
Q3 2013$135,000
-60.1%
10,092
-75.8%
0.00%
Q2 2013$338,00041,6460.00%
Other shareholders
ACCELERATE DIAGNOSTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Birchview Capital, LP 4,387,590$46,772,00015.62%
ORACLE INVESTMENT MANAGEMENT INC 4,091,749$43,618,0005.75%
GRIFFIN ASSET MANAGEMENT, INC. 1,439,613$15,346,0002.36%
Selkirk Management LLC 348,805$3,718,0001.18%
Chicago Capital, LLC 1,966,891$20,967,0001.08%
Trellus Management Company, LLC 46,834$499,0000.51%
Cannell & Co. 1,118,439$11,923,0000.44%
OAKTOP CAPITAL MANAGEMENT II, L.P. 155,000$1,652,0000.36%
Belpointe Asset Management LLC 419,406$3,982,0000.27%
TCI Wealth Advisors, Inc. 55,586$593,0000.23%
View complete list of ACCELERATE DIAGNOSTICS INC shareholders